Federal legislation to protect health data has made little progress. Will that change in the Covid-19 era?
(By Rebecca Robbins for STAT) Before the Covid-19 pandemic, health data privacy wasn’t exactly a hot topic on Capitol Hill.
Read moreMedical Technology
Microsoft, UnitedHealth Group launch COVID-19 app for returning remote workers
(By Laura Dyrda for Becker’s Hospital Review) Microsoft and UnitedHealth Group partnered to launch a new return-to-workplace protocol and COVID-19 symptom
Read moreFDA says Abbott’s 5-minute Covid-19 test may miss infected patients
(By Matthew Herper for STAT) The Food and Drug Administration said late Thursday that the Abbott ID Now rapid test
Read more64% of consumers aren’t confident in accuracy of disease self-screening tools, survey finds
(By Jackie Drees for Becker’s Hospital Review) While healthcare organizations across the globe are deploying self-triage tools to help patients
Read moreFueled by the Covid-19 pandemic, remote heart monitoring could become tech’s next big target
(By Erin Brodwin for STAT) It was a shift that began long before the pandemic: Tech companies, health providers, and
Read more‘No Intubation’: Seniors Fearful Of COVID-19 Are Changing Their Living Wills
(By Judith Graham for Kaiser Health News) DENVER ― Last month, Minna Buck revised a document specifying her wishes should
Read morePhysicians rethinking use of ventilators for some COVID-19 patients
(By Anuja Vaidya for Becker’s Hospital Review) Some COVID-19 patients come to the hospital with low blood oxygen levels — levels
Read moreCOVID Survivors’ Blood Plasma Is A Sought-After New Commodity
(By JoNel Aleccia for Kaiser Health News) Diana Berrent learned she had tested positive for COVID-19 on a Wednesday in
Read moreAt-Home SARS-CoV-2 Diagnostic Tests Could be a Breakthrough, But What Are the Limitations?
(By Brittni Frederiksen, Ivette Gomez, and Alina Salganicoff for Kaiser Family Foundation) The first SARS-CoV-2 diagnostic test with a home collection
Read moreFDA Cracks Down On Antibody Tests For Coronavirus
( By Richard Harris for NPR) The Food and Drug Administration is stiffening its rules to counteract what some have called a
Read more